Page last updated: 2024-09-03

vadimezan and apatinib

vadimezan has been researched along with apatinib in 1 studies

Compound Research Comparison

Studies (vadimezan)	Trials (vadimezan)	Recent Studies (post-2010) (vadimezan)	Studies (apatinib)	Trials (apatinib)	Recent Studies (post-2010) (apatinib)
272	16	101	575	109	544

Protein Interaction Comparison

Protein	Taxonomy	vadimezan (IC50)	apatinib (IC50)
Vascular endothelial growth factor receptor 2	Homo sapiens (human)		0.001

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Ye, G; Zhang, C; Zhang, J	1

Other Studies

1 other study(ies) available for vadimezan and apatinib

Article	Year
Stimulator of interferon response cGAMP interactor overcomes ERBB2-mediated apatinib resistance in head and neck squamous cell carcinoma. Aging, 2021, 08-30, Volume: 13, Issue:16 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Resistance, Neoplasm; Head and Neck Neoplasms; Humans; Interferons; Lapatinib; Male; Membrane Proteins; Mice, Inbred BALB C; Nucleotides, Cyclic; Pyridines; Receptor, ErbB-2; Squamous Cell Carcinoma of Head and Neck; Vascular Endothelial Growth Factor Receptor-2; Xanthones; Xenograft Model Antitumor Assays	2021

Article

Year

Stimulator of interferon response cGAMP interactor overcomes ERBB2-mediated apatinib resistance in head and neck squamous cell carcinoma.

Aging, 2021, 08-30, Volume: 13, Issue:16

Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Resistance, Neoplasm; Head and Neck Neoplasms; Humans; Interferons; Lapatinib; Male; Membrane Proteins; Mice, Inbred BALB C; Nucleotides, Cyclic; Pyridines; Receptor, ErbB-2; Squamous Cell Carcinoma of Head and Neck; Vascular Endothelial Growth Factor Receptor-2; Xanthones; Xenograft Model Antitumor Assays

2021